CRDF vs. ATXS

Last updated Jun 4, 2026

CRDF (Cardiff Oncology, Inc.) and ATXS (Astria Therapeutics, Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. At a 0.21 correlation, their price movements are largely independent.

Performance

CRDF vs. ATXS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Cardiff Oncology, Inc. (CRDF) and Astria Therapeutics, Inc. (ATXS). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

CRDF

• 1D: -7.28%
• 1M: -15.15%
• YTD: -50.18%
• 6M: -34.27%
• 1Y: -60.11%
• 3Y*: -4.94%
• 5Y*: -28.67%
• 10Y*: -42.80%

ATXS

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

CRDF vs. ATXS - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
CRDF Cardiff Oncology, Inc.	-50.18%	-35.25%	193.24%	5.71%	-76.71%	-66.59%	1,350.81%	-60.67%	-85.76%	-85.36%
ATXS Astria Therapeutics, Inc.	-3.90%	46.42%	16.41%	-48.42%	176.25%	-58.02%	-63.79%	35.24%	-70.67%	-58.73%

Correlation

The correlation between CRDF and ATXS is 0.18, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.18
Correlation (3Y) Calculated over the trailing 3-year period	0.18
Correlation (5Y) Calculated over the trailing 5-year period	0.26
Correlation (10Y) Calculated over the trailing 10-year period	0.21
Correlation (All Time) Calculated using the full available price history since Jun 26, 2015	0.21

Fundamentals

Market Cap CRDF : $95.69M ATXS : $729.71M
EPS CRDF : -$0.67 ATXS : -$2.14
PS Ratio CRDF : 194.23 ATXS : 1.03K
PB Ratio CRDF : 2.76 ATXS : 5.29
Total Revenue (TTM) CRDF : $484.00K ATXS : $706.00K
Gross Profit (TTM) CRDF : -$11.32M ATXS : $706.00K
EBITDA (TTM) CRDF : -$45.29M ATXS : -$134.05M

Return for Risk

CRDF vs. ATXS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CRDF

CRDF Risk / Return Rank: 12
CRDF Sharpe Ratio Rank: 12
CRDF Sortino Ratio Rank: 15
CRDF Omega Ratio Rank: 13
CRDF Calmar Ratio Rank: 7
CRDF Martin Ratio Rank: 14

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CRDF vs. ATXS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Cardiff Oncology, Inc. (CRDF) and Astria Therapeutics, Inc. (ATXS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	CRDF	ATXS	Difference
Sharpe ratio Return per unit of total volatility	-0.70	—	—
Sortino ratio Return per unit of downside risk	-0.78	—	—
Omega ratio Gain probability vs. loss probability	0.89	—	—
Calmar ratio Return relative to maximum drawdown	-0.88	—	—
Martin ratio Return relative to average drawdown	-1.21	—	—
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

Sharpe Ratios by Period

	CRDF	ATXS	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.70	—	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.29	—	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	-0.41	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.23	—	—

Drawdowns

Drawdown Indicators

	CRDF	ATXS	Difference
Max Drawdown Largest peak-to-trough decline	-99.96%	—	—
Max Drawdown (1Y) Largest decline over 1 year	-68.54%	—	—
Max Drawdown (3Y) Largest decline over 3 years	-76.31%	—	—
Max Drawdown (5Y) Largest decline over 5 years	-88.36%	—	—
Max Drawdown (10Y) Largest decline over 10 years	-99.82%	—	—
Current Drawdown Current decline from peak	-99.93%	—	—
Average Drawdown Average peak-to-trough decline	-86.17%	—	—
Ulcer Index Depth and duration of drawdowns from previous peaks	49.84%	—	—

Volatility

Volatility by Period

	CRDF	ATXS	Difference
Volatility (1M) Calculated over the trailing 1-month period	31.33%	—	—
Volatility (6M) Calculated over the trailing 6-month period	68.99%	—	—
Volatility (1Y) Calculated over the trailing 1-year period	85.75%	—	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	99.68%	—	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	105.66%	—	—

Dividends

CRDF vs. ATXS - Dividend Comparison

Neither CRDF nor ATXS has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both CRDF and ATXS in my portfolio?

CRDF and ATXS have a correlation of 0.18, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.